Management of women with clear cell endometrial cancer
- 1 May 2009
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 113 (2) , 277-283
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: A Gynecologic Oncology Group studyGynecologic Oncology, 2007
- Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: A Gynecologic Oncology Group studyGynecologic Oncology, 2007
- Precursors of Endometrial Clear Cell CarcinomaAmerican Journal of Surgical Pathology, 2006
- Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial CancerClinical Cancer Research, 2005
- Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2004
- Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2004
- Non-Endometrioid Carcinomas of the Uterine Corpus: A Review of Their Pathology With Emphasis on Recent Advances and Problematic AspectsAdvances in Anatomic Pathology, 2004
- Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Early Pathologic Stage Clear Cell Carcinoma and Uterine Papillary Serous Carcinoma of the EndometriumInternational Journal of Gynecological Pathology, 1995
- Clear cell carcinoma of the endometrium: A histopathological and clinical study of 97 casesGynecologic Oncology, 1990